ORAGENICS INC Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Oragenics Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q4 2024.
  • Oragenics Inc Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $62.7K, a 1603% increase year-over-year.
  • Oragenics Inc Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $516K, a 6.19% decline year-over-year.
  • Oragenics Inc annual Share-based Payment Arrangement, Expense for 2024 was $516K, a 6.19% decline from 2023.
  • Oragenics Inc annual Share-based Payment Arrangement, Expense for 2023 was $550K, a 25.9% decline from 2022.
  • Oragenics Inc annual Share-based Payment Arrangement, Expense for 2022 was $742K.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $516K $62.7K +$59.1K +1603% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-14
Q3 2024 $457K $331K -$72K -17.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $529K $58.2K -$5.41K -8.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $534K $64.3K -$15.7K -19.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $550K $3.68K Oct 1, 2023 Dec 31, 2023 10-K 2025-03-14
Q3 2023 $403K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $63.6K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $80K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2013 $7.62K -$254K -97.1% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-15
Q3 2012 $799K +$587K +277% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-14
Q2 2012 -$3.58K -$731K -100% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-10
Q1 2012 $261K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q3 2011 $212K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $727K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.